Login
$EML
$25.76 +$1.63 (6.76%) Close

Consolidated balance sheets

In millions of USD, except per-share amounts
Q2 FY2027
As of Jul 4, 2026
Q1 FY2027
As of Apr 4, 2026
Q4 FY2026
As of Jan 3, 2026
Q3 FY2026
As of Sep 27, 2025
Q2 FY2026
As of Jun 28, 2025
Q4 FY2026
As of Dec 29, 2025
Q4 FY2025
As of Dec 28, 2024
Q3 FY2025
As of Sep 28, 2024
Q2 FY2025
As of Jun 29, 2024
Q1 FY2025
As of Mar 30, 2024
Q4 FY2024
As of Dec 31, 2023
Q3 FY2024
As of Sep 30, 2023
Q2 FY2024
As of Jul 1, 2023
Q1 FY2024
As of Apr 1, 2023
Q4 FY2023
As of Dec 31, 2022
Q3 FY2023
As of Oct 1, 2022
Q2 FY2023
As of Jul 2, 2022
Q1 FY2023
As of Apr 2, 2022
Q4 FY2022
As of Jan 1, 2022
Q3 FY2022
As of Oct 2, 2021
Current Assets
Cash and cash equivalents
Cash and cash equivalents
Marketable Securities
Accounts receivable, less allowances: 2026 - $681,170; 2025 - $633,391
Raw materials and component parts
Work in process
Finished goods
Inventories
Current portion of notes receivable
Prepaid expenses and other current assets
Current assets held for sale
Total Current Assets
Land
Buildings
Machinery and equipment
Property, Plant and Equipment
Accumulated depreciation
Property, Plant and Equipment, Net
Goodwill
Trademarks
Long term note receivable, less current portion
Patents and other intangibles, net of accumulated amortization
Deferred income taxes
Right of use assets
Long-term assets held for sale
Other Long-term assets
Total Other Assets
TOTAL ASSETS
Current Liabilities
Accounts payable
Accrued compensation
Other accrued expenses
Current portion of operating lease liability
Current portion of finance lease liability
Current portion of long-term debt
Other current liabilities
Current liabilities held for sale
Total Current Liabilities
Other long-term liabilities
Operating lease liability, less current portion
Finance lease liability, less current portion
Long-term debt, less current portion
Accrued postretirement benefits
Accrued pension cost
Long-term liabilities held for sale
Total Liabilities
Shareholders' Equity
Voting Preferred Stock, no par value: Authorized and unissued: 1,000,000 shares
Nonvoting Preferred Stock, no par value: Authorized and unissued: 1,000,000 shares
Common Stock, no par value, Authorized: 50,000,000 shares Issued: 9,195,728 shares as of July 4, 2026 and 9,179,288 shares as of January 3, 2026 Outstanding: 6,017,558 shares as of July 4, 2026 and 6,041,767 shares as of January 3, 2026
Treasury Stock: 3,178,170 shares as of July 4, 2026 and 3,137,521 shares as of January 3, 2026
Retained earnings
Accumulated other comprehensive loss:
Unrealized loss on foreign currency swap, net of tax
Foreign currency translation
Unrealized gain on foreign currency swap, net of tax
Unrecognized net pension and postretirement benefit costs, net of tax
Accumulated other comprehensive loss
Total Shareholders' Equity
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support